Our findings indicate that lower TEK expression correlates with advanced tumor stage, lymph node metastasis, higher histological grade, distant metastasis, and advanced clinical stage in RCC. This evidence concerns the gene TEK and metastatic malignant neoplasm in the lymph nodes.